JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF
BBAX
|
+$1.79B |
| 2 |
JPMorgan BetaBuilders Japan ETF
BBJP
|
+$1.72B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.6B |
| 4 |
Deere & Co
DE
|
+$1.34B |
| 5 |
Amazon
AMZN
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares TIPS Bond ETF
TIP
|
+$1.61B |
| 2 |
Tesla
TSLA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.51B |
| 4 |
Salesforce
CRM
|
+$1.32B |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.13B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 25.65% |
| 2 | Technology | 15.75% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Healthcare | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3251
CALL
Pfizer
PFE
$158B
| $3.15M | ﹤0.01% |
86,800
-1,519,708
| -95% | -$54M |
2014 Q3
26 quarters
|
|
|
AQUA
3252
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $3.14M | ﹤0.01% |
119,423
+26,559
| +29% | +$708K |
2017 Q4
13 quarters
|
|
3253
First Financial Corp
THFF
$892M
| $3.13M | ﹤0.01% |
69,607
-4,492
| -6% | -$191K |
2013 Q2
31 quarters
|
|
3254
ALPS O'Shares U.S. Quality Dividend ETF
OUSA
$714M
| $3.13M | ﹤0.01% |
78,458
+78,227
| +33,865% | +$3.01M |
2020 Q4
1 quarter
|
|
3255
Fulcrum Therapeutics
FULC
$282M
| $3.13M | ﹤0.01% |
265,505
+225,705
| +567% | +$2.79M |
2019 Q3
6 quarters
|
|
|
BRSP
3256
BrightSpire Capital
BRSP
$482M
| $3.12M | ﹤0.01% |
366,627
+26,576
| +8% | +$226K |
2018 Q2
11 quarters
|
|
3257
BlackRock MuniYield Quality Fund III
MYI
$649M
| $3.11M | ﹤0.01% |
218,407
| – | – |
2019 Q4
5 quarters
|
|
|
ZYXI
3258
DELISTED
Zynex
ZYXI
| $3.1M | ﹤0.01% |
223,685
+11,810
| +6% | +$180K |
2019 Q1
8 quarters
|
|
3259
Pegasystems
PEGA
$5.58B
| $3.1M | ﹤0.01% |
54,198
+14,544
| +37% | +$951K |
2013 Q2
31 quarters
|
|
3260
BlackRock Municipal 2030 Target Term Trust
BTT
$1.4B
| $3.09M | ﹤0.01% |
121,567
+3,627
| +3% | +$92.5K |
2015 Q2
23 quarters
|
|
3261
State Street SPDR S&P Transportation ETF
XTN
$307M
| $3.09M | ﹤0.01% |
35,268
+29,796
| +545% | +$2.36M |
2017 Q1
16 quarters
|
|
|
BCLI
3262
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
| $3.08M | ﹤0.01% |
53,696
+27,535
| +105% | +$2.08M |
2019 Q4
5 quarters
|
|
|
NEXI
3263
DELISTED
NexImmune, Inc. Common Stock
NEXI
| $3.08M | ﹤0.01% |
+6,466
| New | +$3.52M |
2021 Q1
0 quarters
|
|
|
SCWX
3264
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
| $3.08M | ﹤0.01% |
230,273
-38,863
| -14% | -$562K |
2016 Q3
18 quarters
|
|
3265
CALL
Dollar General
DG
$26.2B
| $3.08M | ﹤0.01% |
15,200
+14,900
| +4,967% | +$2.96M |
2020 Q4
1 quarter
|
|
|
KBAL
3266
DELISTED
Kimball International
KBAL
| $3.08M | ﹤0.01% |
219,984
-23,260
| -10% | -$302K |
2013 Q2
31 quarters
|
|
3267
AMERISAFE
AMSF
$437M
| $3.08M | ﹤0.01% |
48,098
+21,068
| +78% | +$1.27M |
2013 Q2
31 quarters
|
|
|
CVA
3268
DELISTED
Covanta Holding Corporation
CVA
| $3.08M | ﹤0.01% |
221,844
+137,808
| +164% | +$1.97M |
2013 Q2
31 quarters
|
|
3269
1-800-Flowers.com
FLWS
$164M
| $3.07M | ﹤0.01% |
111,342
+90,229
| +427% | +$2.68M |
2017 Q4
13 quarters
|
|
|
HONE
3270
DELISTED
HarborOne Bancorp
HONE
| $3.07M | ﹤0.01% |
227,709
+41,926
| +23% | +$510K |
2017 Q4
13 quarters
|
|
3271
CALL
Manulife Financial
MFC
$71.1B
| $3.07M | ﹤0.01% |
+142,700
| New | +$2.84M |
2021 Q1
0 quarters
|
|
|
RC
3272
Ready Capital
RC
$187M
| $3.07M | ﹤0.01% |
228,563
-82,736
| -27% | -$1.07M |
2016 Q1
20 quarters
|
|
3273
PUT
3M
MMM
$83.5B
| $3.06M | ﹤0.01% |
19,016
-141,726
| -88% | -$21.2M |
2016 Q2
19 quarters
|
|
3274
Tennant Co
TNC
$1.14B
| $3.06M | ﹤0.01% |
38,330
+11,608
| +43% | +$880K |
2013 Q2
31 quarters
|
|
|
3275
PUT
Pfizer
PFE
$158B
| $3.06M | ﹤0.01% |
84,500
-806,472
| -91% | -$28.6M |
2013 Q2
31 quarters
|
|
Similar funds
JP Morgan Chase's Q1 2021 Portfolio in Review
As of Q1 2021, JP Morgan Chase held 6,599 positions worth $749B, up 10% from $681B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
JP Morgan Chase deployed $36.2B of net new capital in Q1 2021, opening 866 new positions and adding to 2,869 existing holdings. Its largest new stake was Ferguson: 4,925,283 shares worth $592M.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares TIPS Bond ETF, an estimated $1.61B trimmed.
- JP Morgan Chase's largest Q1 2021 buy was Ferguson: 4,925,283 shares worth $592M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Developed Asia Pacific-ex Japan ETF in Q1 2021, an estimated $1.79B increase.
- JP Morgan Chase's biggest Q1 2021 reduction was iShares TIPS Bond ETF, cutting an estimated $1.61B.
- JP Morgan Chase fully exited TC Pipelines LP in Q1 2021, selling an estimated $65.2M.
- JP Morgan Chase's ten largest holdings make up 15% of its $749B portfolio in Q1 2021.
- JP Morgan Chase opened 866 new positions and closed 461 in Q1 2021.
- JP Morgan Chase's portfolio value rose 10% quarter-over-quarter to $749B.
Based on JP Morgan Chase's 13F filing for Q1 2021, filed 12 May 2021.